• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RCKT

RCKT

Rocket Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.96

+0.04 (+1.20%)

Rating:C+

Company Profile

CEO

Gaurav D. Shah

IPO Date

2015-02-18

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.93

Prev. Close

$2.92

Day Low

$2.92

Day High

$3.04

52W Low

$2.40

52W High

$5.45

Market Cap

$0.32B

Volume

1.28M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.5%

Avg Negative

1.3%

Avg Neutral

69.2%

News Feed

Rocket Pharmaceuticals Announces Positive Data From RP-L102, RP-L201 Gene Therapy Programs

Benzinga·5/13/2021·↑ positive

Rocket Pharmaceuticals Announces Participation at Upcoming Conferences

Business Wire·2/18/2021·↑ positive

Rocket Pharmaceuticals: Moving Closer To A Potential Launch

Seeking Alpha·2/11/2021·↑ positive

Reddit playing a major role in biotech trading action, says Jefferies top health care analyst

CNBC Television·2/4/2021·↑ positive

Rocket Pharmaceuticals Announces Buildout of R&D and Manufacturing Facility to Support Development of Innovative Gene Therapy Pipeline

Business Wire·1/11/2021·↑ positive

Rocket Pharmaceuticals Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference

Business Wire·1/6/2021·↑ positive

5 Medical Outperformers That Might Lose Steam in 2021

Zacks Investment Research·12/22/2020·↑ positive

Rocket Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Business Wire·12/14/2020·↑ positive

Rocket Pharmaceuticals Prices Upsized Public Offering of Common Stock

Business Wire·12/9/2020·↑ positive

These Biotech Stock Market Winners Have Nothing to Do With COVID-19

The Motley Fool·12/9/2020·↑ positive